Literature DB >> 9401434

Hepatic tumors in patients with cirrhosis: an autopsy study.

A Ruiz Guinaldo1, L Martín Herrera, R Roldán Cuadra.   

Abstract

The incidence and characteristics of hepatic tumors -primitive or secondary- were analyzed in a series of 596 patients with cirrhosis and on whom an autopsy was carried out. A hepatic tumor was discovered in 43.6%: 96.5% with histological findings of malignant disease and only 3.4% with benign disease. The tumors discovered showed the following in order of frequency: hepatocellular carcinoma (90.3%), hepatic metastases (4.2%), cholangiocarcinoma (2.3%), adenoma (1.5%), hemangioma (1.2%) and hamartoma (0.8%). Therefore, 10% of the neoplasms located in the cirrhotic liver were different from the hepatocellular carcinoma. In 2% of the subjects with hepatic tumors, two histologically different lesions were found to co-exist in the liver, and in every case it was found to be a hepatocellular carcinoma related to another tumor, which further complicated the diagnosis. The most frequent type of hepatocellular carcinoma was multinodular, although diffuse tumors most frequently developed metastases. When the hepatocellular carcinoma was uninodular and small, distal spread was exceptional. Metastatic infiltration of the liver by neoplasms of different origin, characteristically infrequent in cirrhosis, was always accompanied by spread to other organs and did not appear as a single nodule in any case. We conclude that the correct diagnosis of tumor-related lesions located, in a cirrhotic liver is occasionally difficult during life, especially when the neoplasms are different from the hepatocellular carcinoma.

Entities:  

Mesh:

Year:  1997        PMID: 9401434

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  1 in total

1.  Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients.

Authors:  Tanja Eva-Maria Kaltenbach; Phillip Engler; Wolfgang Kratzer; Suemeyra Oeztuerk; Thomas Seufferlein; Mark Martin Haenle; Tilmann Graeter
Journal:  Abdom Radiol (NY)       Date:  2016-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.